ALA arovella therapeutics limited

onCARlytics update

  1. 2,344 Posts.
    lightbulb Created with Sketch. 347
    Yesterday's announcement of the safe progression of the lead-in study using only the CD19 expressing oncolytic virus is also good news for Arovella (if the ALA-101 / onCARlytics in vivo trial is successful).
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
8.7¢
Change
0.007(8.75%)
Mkt cap ! $101.6M
Open High Low Value Volume
8.1¢ 8.7¢ 8.1¢ $112.8K 1.341M

Buyers (Bids)

No. Vol. Price($)
3 9363 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 256684 3
View Market Depth
Last trade - 13.11pm 16/09/2025 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.